INS and type 1 diabetes mellitus: Looking to the future and precision medicine, due to the apparent heterogeneity of peptide reactivity in T1D patients as well as in NOD mice, the most effective therapy may require induction of tolerance to multiple antigens, perhaps two or more hybrid insulin peptides, for durable preservation of islet function.